Legal Representation
Attorney
Joshua S. Schoonover
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 13, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 13, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 25, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 24, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 24, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 27, 2020 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Feb 26, 2020 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Feb 26, 2020 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Feb 26, 2020 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Jan 13, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 13, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 11, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 11, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 16, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 16, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 27, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 5, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 5, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 20, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 7, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing scientific research information in the field of immuno-oncology
Additional Information
Pseudo Mark
TWO FOR
Classification
International Classes
042